TGFB1 and cancer: In TNBC and certain other late-stage tumors, TGF-β signaling cannot suppress cell proliferation and induces and/or enhances epithelial-to-mesenchymal transition (EMT), a cellular program that promotes cancer cell intravasation, immune evasion5 and confers cancer stem cells traits associated with high-grade malignancy6–9.